Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series

[1]  G. Lippi,et al.  Is there a correlation between MOG‐associated disorder and SARS‐CoV‐2 infection? , 2022, European journal of neurology.

[2]  C. Bien,et al.  MOG antibody-associated encephalitis secondary to Covid-19: case report , 2021, BMC Neurology.

[3]  O. Ciccarelli,et al.  Myelin-oligodendrocyte glycoprotein antibody-associated disease , 2021, The Lancet Neurology.

[4]  K. Kashiwagi,et al.  Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient , 2021, Medicine.

[5]  S. Farhadian,et al.  MOG-associated encephalitis following SARS-COV-2 infection , 2021, Multiple Sclerosis and Related Disorders.

[6]  K. Sawalha,et al.  COVID-19-Induced Acute Bilateral Optic Neuritis , 2020, Journal of investigative medicine high impact case reports.

[7]  C. Azevedo,et al.  Myelin Oligodendrocyte Glycoprotein Antibody–Associated Optic Neuritis and Myelitis in COVID-19 , 2020, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[8]  A. Vojdani,et al.  Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases , 2020, Clinical Immunology.

[9]  J. Mills,et al.  A multicenter comparison of MOG-IgG cell-based assays , 2019, Neurology.

[10]  G. Cantalupo,et al.  Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study , 2017, Journal of Neurology.